#102: TheMachine: COPAXONE(R) Demonstrated Protective Effect in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
PreCISe Data Presented at World Congress on Treatment and Research in... |
September 20, 2008
01:18:32 AM |
#101: TheMachine: Teva Completes Acquisition of Bentley Pharmaceuticals
-Teva Gains a Strong Platform to Become a Leading Player in Spain-
... |
July 27, 2008
07:19:07 AM |
#100: NewsBot: TEVA News Teva Provides Update on Generic Celebrex(R) Litigation
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA)... |
March 21, 2007
07:15:00 AM |
#99: NewsBot: TEVA News Teva Receives First U.S. Approval for Generic Uniretic(R) Tablets
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
March 9, 2007
06:50:00 AM |
#98: NewsBot: TEVA News Teva Receives Approval for Generic Dostinex(R) Tablets
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:... |
March 8, 2007
08:18:00 AM |
#97: NewsBot: TEVA News Teva Announces the Office of the Chief Executive Officer
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
March 7, 2007
09:36:00 AM |
#96: NewsBot: TEVA News Teva to Sell Oxycodone Through the End of 2007
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
March 6, 2007
05:25:00 AM |
#95: NewsBot: TEVA News Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
March 5, 2007
05:18:00 AM |
#94: NewsBot: TEVA News Teva Announces Approval of Alprazolam ER Tablets
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA)... |
March 1, 2007
08:22:00 AM |
#93: NewsBot: TEVA News Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
February 22, 2007
06:48:00 AM |
#92: NewsBot: TEVA News Teva Reports Fourth Quarter and Full Year 2006 Results
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA)... |
February 12, 2007
10:05:00 PM |
#91: NewsBot: TEVA News Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 300 mg Under Agreement with Anchen and IMPAX
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ:... |
December 18, 2006
05:00:00 AM |
#90: NewsBot: TEVA News Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
November 29, 2006
12:28:00 AM |
#89: NewsBot: TEVA News Teva Announces Approval of Ondansetron Injection USP
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:... |
November 22, 2006
10:42:00 AM |
#88: NewsBot: TEVA News Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA)... |
November 21, 2006
05:48:00 AM |
| 
| 
| 
| 
| 
| 
